PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsrenal dialysis
MeSH D006435 - renal dialysis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017582:Renal replacement therapy
0 Companies
0 Drugs
Success rate
D006435: 
Renal dialysis
3 Companies
2 Drugs
$
Success rate
D006437:Home hemodialysis
0 Companies
0 Drugs
Success rate
D010530:Peritoneal dialysis
0 Companies
0 Drugs
Success rate
D017583:Hemodiafiltration
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
SanofiSevelamer Renagel  2000-01-28   
Sevelamer Renvela  2009-06-09   
Sevelamer Tasermity  2015-02-25   
Sevelamer Sevelamer Winthrop (previously Sevelamer Zentiva)  2015-01-15   
ViforSucroferric oxyhydroxide Velphoro  2014-08-26   
Clinical Trials
Historical Success Rate
Phase 1
38%
5/13
Phase 2
70%
19/27
Phase 3
43%
10/23
Approved: 2Overall Success rate: 12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Sanofi
Sevelamer carbonate,
Sevelamer,
Calcium carbonate,
Corticorelin,
Tums,
Antacid
Vifor
Sucroferric oxyhydroxide
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use